Rheumatology Advisor

Predictive Model Shows Moderate Performance for Psoriasis Relapse Risk

A predictive model for psoriasis relapse risk demonstrates moderate performance, according to results of a recent study.
The American Journal of Managed Care

Predictive Biomarker Testing for Immunotherapy in Melanoma

Antoni Ribas, MD, PhD: For certain cancers where we know it can only work in a specific situation that has a specific marker, having a companion diagnostic makes a lot of sense. You want to select ...
Seeking Alpha

Fujifilm and Predictive Oncology Announce Collaboration to Reduce Protein Interference in Bacterial Endotoxin Detection Testing of Biopharmaceuticals

RICHMOND, VA, and PITTSBURGH, April 25, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Wako Chemicals U.S.A. Corporation (Fujifilm), a supplier of high purity chemicals and reagents, and Predictive Oncology Inc., ...
ascopubs.org

PERSIAN trial (NCT03449719): Predictive features of complete biochemical response within a randomized phase II trial testing apalutamide and stereotactic body radiation therapy ...

A randomized phase 2 study of enhanced AR blockade with enzalutamide in high-risk patients with biochemical relapse undergoing salvage radiation: Final results from RTOG 3506 (STEEL). This is an ASCO ...